 |
Video: What is a Stock Split?
|
 |
Ayala Pharmaceuticals is a clinical stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. Co.'s portfolio of product candidates, AL101 and AL102, targets the aberrant activation of the Notch pathway using gamma secretase inhibitors. Gamma secretase is the enzyme responsible for Notch activation and, when inhibited, turns off the Notch pathway activation. Aberrant activation of the Notch pathway has long been implicated in various solid tumor and hematological cancers and has often been associated with more aggressive cancers. According to our ADXS split history records, ADXS has had 2 splits. | |
 |

ADXS (ADXS) has 2 splits in our ADXS split history database. The first split for ADXS took place on July 15, 2013. This was a 1 for 125 reverse split, meaning for each 125 shares of ADXS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 8 share position following the split. ADXS's second split took place on March 29, 2019. This was a 1 for 15 reverse split, meaning for each 15 shares of ADXS owned pre-split, the shareholder now owned 1 share. For example, a 8 share position pre-split, became a 0.533333333333333 share position following the split.
When a company such as ADXS conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ADXS split history from start to finish, an original position size of 1000 shares would have turned into 0.533333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ADXS shares, starting with a $10,000 purchase of ADXS, presented on a split-history-adjusted basis factoring in the complete ADXS split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/17/2015 |
|
End date: |
08/03/2022 |
|
Start price/share: |
$112.50 |
|
End price/share: |
$3.92 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-96.52% |
|
Average Annual Total Return: |
-36.23% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$348.65 |
|
Years: |
7.46 |
|
|
 |
Date |
Ratio |
07/15/2013 | 1 for 125 | 03/29/2019 | 1 for 15 |
|
 |